Skip to main content

Advertisement

SpringerLink
Log in

Role of p53 Arg72Pro SNP in the pathogenesis of gliomas and its effect on serum level of p53

  • Original Article
  • Published:
Comparative Clinical Pathology Aims and scope Submit manuscript

Abstract

Gliomas account for almost 80 % of primary malignant brain tumors and are a major cause of morbidity and mortality more than any other tumor. The p53 gene is a tumor suppressor gene that plays a role in genomic stability, cell cycle control, and DNA repair after damage and apoptosis. Malfunction of the p53 pathway is a universal hallmark of human tumors with p53 codon 72 polymorphism reported to affect regulatory networks central to glioma development. The aim of work was to investigate the role of p53 Arg72Pro single nucleotide polymorphism (SNP) in the pathogenesis of gliomas and its effect on the serum level of p53. Forty-five glioma patients and 50 control subjects were included for whom genotyping for p53 Arg72Pro SNP by polymerase chain reaction-restriction fragment length polymorphism as well as measurement of serum p53 level were done. No statistically significant difference was observed in genotype distribution or allele frequency between cases and control and nor was there a significant difference in serum p53 level. In conclusion, in our work, no association was detected between p53 Arg72Pro SNP and the pathogenesis of gliomas, and neither was there an observed effect for the different genotypes on serum p53 levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Abdel-Aziz MM, Gad El-hak NA, Abbas T (2005) Clinical significance of serum p53 antigen in patients with hepatocellular carcinoma. Int J Cancer Res 1:94–100

    Article  Google Scholar 

  • Balogh GA, Corte MM, Roncoroni P, Nardi H, Vincent E, Martinez D, Cafasso ME, Frizza A, Ponce G, Vincent E, Barutta E, Lizarraga P, Lizarraga G, Monti C, Paolillo E, Vincent R, Quatroquio R, Maturi H, Aimale M, Spinsanti C, Montero H, Santiago J, Shulman L, Rivadulla M, Machiavelli M, Salum M, Cuevas MA, Picolini J, Mailo D, Gentili A, Gentili R, Mordoh J (2006) Detection of mutant p53 protein in serum could be used to differentiated malignant from benign breast tumors. Int J Oncol 28:995–1002

    CAS  PubMed  Google Scholar 

  • Beckman G, Birgander R, Själander A, Saha N, Holmberg PA, Kivelä A, Beckman L (1994) Is p53 polymorphism maintained by natural selection? Hum Hered 44:266–270

    Article  CAS  PubMed  Google Scholar 

  • Butowski NA, Chang SM (2006) Glial tumors: the current state of scientific knowledge. Clin Neurosurg 53:106–113

    PubMed  Google Scholar 

  • CBTRUS (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004–2008. Source: Central Brain Tumor Registry of the United States, Hinsdale, IL. At www.cbtrus.org. Accessed 16 Mar 2012

  • Charuruks N, Tangkjvanich P, Voravud N, Chatsantikul R, Theamboonlers A, Poovorawan Y (2001) Clinical significance of p53 antigen and anti-p53 antibodies in the sera of hepatocellular carcinoma patients. J Gasteroenterol 36:830–836

    Article  CAS  Google Scholar 

  • Darabi M, Meibodi NT, Mahdavi R, Arab D (2006) p53 Protein in serum and urine samples of patients with bladder transitional cell carcinoma and its overexpression in tumoral tissue. Urol J 3:216–219

    PubMed  Google Scholar 

  • El Hallani S, Ducray F, Idbaih A, Marie Y, Boisselier B, Colin C, Laigle-Donadey F, Rodéro M, Chinot O, Thillet J, Hoang-Xuan K, Delattre JY, Sanson M (2009) TP53 codon 72 polymorphism is associated with age at onset of glioblastoma. Neurology 72:332–336

    Article  CAS  PubMed  Google Scholar 

  • Hu X, Pandolfi PP, Li Y, Koutcher JA, Rosenblum M, Holland EC (2005) mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia 7:356–368

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hussein MR, El-Ghorori RM, El-Rahman YG (2006) Alterations of p53, BCL-2, and hMSH2 protein expression in the normal brain tissues, gliosis, and gliomas. Int J Exp Pathol 87:297–306

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ji X, Neumann AS, Sturgis EM, Adler-Storthz K, Dahlstrom KR, Schiller JT, Wei Q, Li G (2008) p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in neversmokers. Carcinogenesis 29:875–879

    Article  CAS  PubMed  Google Scholar 

  • Kuroda Y, Nakao H, Ikemura K, Katoh T (2007) Association between the TP53 codon 72 polymorphism and oral cancer risk and prognosis. Oral Oncol 43:1043–1048

    Article  CAS  PubMed  Google Scholar 

  • Li X, Dumont P, Della PA, Shetler C, Murphy ME (2005) The codon 47 polymorphism in p53 is functionally significant. J Biol Chem 280:24245–24251

    Article  CAS  PubMed  Google Scholar 

  • Lima-Ramos V, Pacheco-Figueiredo L, Costa S, Pardal F, Silva A, Amorim J, Lopes JM, Reis RM (2008) TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas. Cancer Genet Cytogenet 180:14–19

    Article  CAS  PubMed  Google Scholar 

  • Lutz W, Nowakowska-Świrta E (2002) Gene p53 mutations, protein p53, and anti-p53 antibodies as biomarkers of cancer process. Int J Occup Med Environ Health 15:209–218

    PubMed  Google Scholar 

  • Madeleine MM, Shera K, Schwartz SM, Daling JR, Galloway DA, Wipf GC, Carter JJ, McKnight B, McDougall JK (2000) The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer. Cancer Epidemiol Biomark Prev 9:225–227

    CAS  Google Scholar 

  • Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N (2007) Molecular pathogenesis of pediatric astrocytic tumors. Neuro Oncol 9:113–123

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ohgaki H, Kleihues P (2007) Genetic pathways to primary and secondary glioblastomas. Am J Pathol 170:1445–1453

    Article  CAS  PubMed  Google Scholar 

  • Parhar P, Ezer R, Shaob Y, Allen JC, Miller DC, Newcomb EW (2005) Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas. Mol Brain Res 137:98–103

    Article  CAS  PubMed  Google Scholar 

  • Peixoto Guimaraes D, Hsin Lu S, Snijders P, Wilmotte R, Herrero R, Lenoir G, Montesano R, Meijer CJ, Walboomers J, Hainaut P (2001) Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Lett 162:231–235

    Article  CAS  PubMed  Google Scholar 

  • Pinto GR, Yoshioka FKN, Silva RLL, Clara CA, Santos MJ, Almeida JRW, Burbano RR, Rey JA, Casartelli C (2008) Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymorphisms and the susceptibility to gliomas in individuals from southeast Brazil. Genet Mol Res 7:207–216

    Article  CAS  PubMed  Google Scholar 

  • Sanai N, Berger MS (2009) Operative techniques for gliomas and the value of extent of resection. Neurotherapeutics 6:478–486

    Article  PubMed  Google Scholar 

  • Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2:494–503

    Article  PubMed  Google Scholar 

  • Shi M, Huang R, Pei C, Jia X, Jiang C, Ren H (2012) TP53 codon 72 polymorphism and glioma risk: a meta-analysis. Onc Lett 3:599–606

    CAS  Google Scholar 

  • Wang LE, Bondy ML, Shen H, El-Zein R, Aldape K, Cao Y, Pudavalli V, Levin VA, Yung WKA, Wei Q (2004) Polymorphisms of DNA repair genes and risk of glioma. Cancer Res 64:5560–5563

    Article  CAS  PubMed  Google Scholar 

  • World Medical Association (2008) Declaration of Helsinki. Ethical principles for medical research involving human subjects, the 59th WMA General Assembly, Seoul, South Korea

  • Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ (1999) A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 29:697–702

    Article  CAS  PubMed  Google Scholar 

  • Zalata KR, El-Tantawy DA, Abdel-Aziz A, Ibraheim AM, Halaka AH, Gawish HH, Safwat M, Mansour N, Mansour M, Shebl A (2011) Frequency of central nervous system tumors in delta region, Egypt. Indian J Pathol Microbiol 54:299–306

    Article  PubMed  Google Scholar 

  • Zawlik I, Kita D, Vaccarella S, Mittelbronn M, Franceschi S, Ohgaki H (2009) Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas. Brain Pathol 19:188–194

    Article  CAS  PubMed  Google Scholar 

  • Zhu ZZ, Wang AZ, Jia HR, Jin XX, He XL, Hou LF, Zhu G (2007) Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population. Jpn J Clin Oncol 37:385–390

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chemical Pathology Department, Cairo University and Hospitals, Cairo, Egypt

    Nadida Gohar, Mohamed Shehata, Dina ElAbd, Reham Zeyada & Riham Hanafy

  2. Neurosurgery Department, Cairo University and Hospitals, Cairo, Egypt

    Khaled Anbar & Mohamed El Borady

Authors
  1. Nadida Gohar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamed Shehata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dina ElAbd
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Reham Zeyada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Riham Hanafy
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Khaled Anbar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mohamed El Borady
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reham Zeyada.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gohar, N., Shehata, M., ElAbd, D. et al. Role of p53 Arg72Pro SNP in the pathogenesis of gliomas and its effect on serum level of p53. Comp Clin Pathol 23, 83–89 (2014). https://doi.org/10.1007/s00580-012-1574-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00580-012-1574-7

Keywords

Search

Navigation